Verdane exits clinical trials company – updated
Verdane initially invested in CRF Health by buying 100 percent of Nordic Venture Partners I in 2013.
8 January 2015•2 mins read
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence- Curated insights to keep you ahead of GP-led and LP-led secondaries
- Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
- Access to proprietary research and reports
- Selected fund performance and investor activity data